Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023
Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023
SEATTLE, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or "Nautilus"), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results for the third quarter before market open on Tuesday, October 31, 2023.
西雅图，2023年10月11日(环球网)--领先的单分子蛋白质分析平台公司鹦鹉螺生物技术公司(纳斯达克：NAUT；或“Nautilus”)今天宣布，将于2023年10月31日(星期二)开市前公布第三季度财务业绩。
The company's management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the "Investors" section of the company website at: www.nautilus.bio.
该公司管理层将于凌晨5：30开始网络直播相应的电话会议。太平洋时间/上午8：30东部时间讨论其业绩、业务发展和前景。网络直播的现场音频将在该公司网站的“投资者”栏目中播放，网址为：Www.nautilus.bio。
About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus' mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.
鹦鹉螺生物技术公司简介
Nautilus公司总部设在华盛顿州西雅图，研发总部设在加利福尼亚州圣卡洛斯，是一家处于发展阶段的生命科学公司，致力于创建一种量化和解锁蛋白质组复杂性的平台技术。Nautilus的使命是通过使获得蛋白质组的途径民主化并使人类健康和医学取得根本性进展来改变蛋白质组学领域。要了解更多有关鹦鹉螺的信息，请访问Www.nautilus.bio。
Media Contact
press@nautilus.bio
媒体联系人
邮箱：Press@nautilus.bio
Investor Contact
investorrelations@nautilus.bio
投资者联系方式
邮箱：Investorrelationsnautilus.bio